Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Atavistik Bio, Inc

Clinical trials sponsored by Atavistik Bio, Inc, explained in plain language.

Not yet finished but already full! 1

New pill targets Cancer's genetic weakness in first human trial

Disease control Ongoing

This is a first-in-human study to find a safe dose and see how the body processes a new oral drug called ATV-1601. It is being tested in adults with advanced solid tumors, including certain breast cancers, that have a specific genetic change called an AKT1 E17K mutation. The main…

Phase: PHASE1 • Sponsor: Atavistik Bio, Inc • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC